Learn More
Medchemexpress LLC Galanthamine hydrobromide | 1953-04-4 | MFCD00067672 | 99.9% | C17H22BrNO3 | 100 MG

Supplier: Medchemexpress LLC HYA0009100MG
Galanthamine hydrobromide is a selective, reversible, and competitive alkaloid acetylcholinesterase (AChE) inhibitor with an IC50 of 0.35 μM. It also acts as a potent allosteric potentiating ligand (APL) for human α3β4, α4β2, and α6β4 nicotinic receptors (nAChRs). This compound is developed for research related to Alzheimer's disease (AD).
- Selective, reversible, competitive AChE inhibitor
- Potent allosteric potentiating ligand for human nicotinic receptors
- Reduces cognitive deficits in APP23 mice
- Protects against Aβ toxicity in SH-SY5Y cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.